Price T Rowe Associates Inc Cardlytics, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Cardlytics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 31,574 shares of CDLX stock, worth $143,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,574
Previous 29,769
6.06%
Holding current value
$143,661
Previous $432,000
39.81%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CDLX
# of Institutions
141Shares Held
34.1MCall Options Held
946KPut Options Held
942K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.46MShares$29.4 Million4.15% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$14.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$11 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.17MShares$9.85 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.1MShares$9.56 Million1.57% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $150M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...